A case of cutaneous T cell lymphoma treated with recombinant interleukin 2 (rIL-2). 1988

T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
Department of Dermatology, Yokohama City University School of Medicine, Japan.

We report a case of cutaneous T cell lymphoma (CTCL) treated with local injection of recombinant interleukin 2 (rIL-2). The biopsy specimen showed marked infiltration of large convoluted cells admixed with small lymphocytes and histiocytes in the epidermis, dermis and subcutis. After six injections of rIL-2, 4 nodules out of 5 on the left lower leg disappeared and the remaining large nodule was diminished in size. A biopsy specimen from the diminished nodule showed infiltration of small lymphocytes with histiocytes and plasma cells in the dermis. The atypical cells, large hyperconvoluted lymphocytes, had disappeared. A large number (28%) of lysozyme- and alpha 1-anti-chymotrypsin-positive cells were demonstrated by immunohistochemistry. The patient maintained complete remission for a period of 13 months. He then noticed a small red nodule on the back of the left foot, which was histologically confirmed as a recurrence. Chemotherapy cleared the lesion.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
May 1995, Archives of dermatology,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
May 1997, Archives of dermatology,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
March 1990, British journal of cancer,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
May 2002, Journal of biotechnology,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
January 1993, European journal of cancer (Oxford, England : 1990),
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
June 1993, Cancer,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
August 2000, Journal of the American Academy of Dermatology,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
February 2001, Journal of the American Academy of Dermatology,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
January 2009, Journal of the American Academy of Dermatology,
T Nagatani, and S T Kin, and N Baba, and H Miyamoto, and H Nakajima, and Y Katoh
July 1992, The British journal of dermatology,
Copied contents to your clipboard!